MELEXANTA Trademark

Trademark Overview

On Wednesday, July 24, 2002, a trademark application was filed for MELEXANTA with the United States Patent and Trademark Office. The USPTO has given the MELEXANTA trademark a serial number of 78147178. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 8, 2013. This trademark is owned by AstraZeneca AB. The MELEXANTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases.

General Information

Serial Number78147178
Word MarkMELEXANTA
Filing DateWednesday, July 24, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 8, 2013
Registration Number3111093
Registration DateTuesday, July 4, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 11, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 8, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSodertalje S-151 85
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje S-151 85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje S-151 85
SE

Trademark Events

Event DateEvent Description
Friday, February 8, 2013CANCELLED SEC. 8 (6-YR)
Tuesday, July 24, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 24, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 4, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, April 11, 2006PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2006NOTICE OF PUBLICATION
Tuesday, February 28, 2006AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED
Wednesday, February 1, 2006PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, December 15, 2005PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Thursday, December 15, 2005PAPER RECEIVED
Tuesday, August 2, 2005EXTENSION 4 GRANTED
Wednesday, June 29, 2005EXTENSION 4 FILED
Wednesday, June 29, 2005TEAS EXTENSION RECEIVED
Friday, January 14, 2005EXTENSION 3 GRANTED
Monday, December 27, 2004EXTENSION 3 FILED
Monday, December 27, 2004TEAS EXTENSION RECEIVED
Tuesday, July 20, 2004EXTENSION 2 GRANTED
Monday, June 28, 2004EXTENSION 2 FILED
Wednesday, July 7, 2004CASE FILE IN TICRS
Monday, June 28, 2004TEAS EXTENSION RECEIVED
Saturday, March 27, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 22, 2004EXTENSION 1 GRANTED
Monday, December 29, 2003EXTENSION 1 FILED
Monday, December 29, 2003TEAS EXTENSION RECEIVED
Tuesday, July 1, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 8, 2003PUBLISHED FOR OPPOSITION
Wednesday, March 19, 2003NOTICE OF PUBLICATION
Wednesday, February 12, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 11, 2003ASSIGNED TO EXAMINER

Related Keywords

melexanta diseases cardiovascular treatment preparations pharmaceutical